Skip to main content
. 2019 Aug 20;4(4):e00293-19. doi: 10.1128/mSystems.00293-19

FIG 1.

FIG 1

(a to c) Experimental design that sampled skin microbiota from AD-active children and healthy controls in the two Chinese cities of Beijing (a) and Qingdao (b) and the American city of Denver (c). In diseased children, skin microbiota from both lesional sites and the nonlesional sites were collected (Fig. 5a for details). In healthy children, the sampling sites were matched with the lesional sites of patients. For the Beijing cohort, skin microbiota before and after various treatment regimens was sampled.